Arcellx's anito-cel shows promising efficacy and safety in multiple myeloma. Read why I maintain my hold rating for ACLX ...

Moderna is down 80% from its 52-week high as revenues continue to fall and the new RSV vaccine has performed poorly. Read my ...

Glaukos GKOS recently announced positive data from a new 36-month follow-up analysis of its two Phase 3 pivotal clinical ...

Iron Road Ltd ( ($AU:IRD) ) has issued an announcement. Iron Road Ltd has announced significant progress in a Scoping Study conducted by WSP, ...

Electric vehicle (EV) stocks like Amara Raja, Bharat Electronics (BEL), Bharat Forge and Minda Corporation among others gained up to 6% in trade on Tuesday, January 14, following a study released ...

As the New Year ushers in the so-called Dry January movement, a recent study shows that no- and low-alcohol beverages are becoming increasingly popular, particularly among millennials.

The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study in patients with high-risk non-muscle invasive bladder cancer (NMIBC ...

Neumora Therapeutics announced the failure of its lead pipeline candidate, navacaprant, in a late-stage study for major depressive ... Teva has agreed not to market its generic version of Firdapse ...

The study, conducted across 15 top-rated tertiary care hospitals in India, focused on patients with severe infections, ...

The U.S. Securities and Exchange Commission (SEC) was extremely busy in 2024, finalizing a multitude of new rules. A few targeted exchanges and their fee structures, including reducing access fees and ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Shell got one. So did the pipeline company Enbridge. And last summer, energy giant Drax got its biggest one to date, worth more than half a billion dollars.